| |
 |
|
Class Information
Number: 514/43
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > N-glycoside > Nitrogen containing hetero ring
Description: Subject matter wherein the aglycone portion contains a nitrogen containing hetero ring.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/52 |
Phosphorus containing (e.g., vitamin b12, etc.) |
258 |
| 514/44 |
Polynucleotide (e.g., rna, dna, etc.) |
3,242 |
| 514/45 |
Purines (including hydrogenated) (e.g., adenine, guanine, etc.) |
540 |
| 514/49 |
Pyrimidines (including hydrogenated) (e.g., cytosine, etc.) |
504 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6376470 |
Polymer conjugates of ara-C and ara-C derivatives |
Apr. 23, 2002 |
| 6372725 |
Specific lipid conjugates to nucleoside diphosphates and their use as drugs |
Apr. 16, 2002 |
| 6342485 |
Synergistic compositions useful as anti-tumor agents |
Jan. 29, 2002 |
| 6342484 |
Method and compositions for promotion of wound treatment |
Jan. 29, 2002 |
| 6335323 |
Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin B12 and/or precursors or inducers of a neurotransmitter |
Jan. 1, 2002 |
| 6323187 |
Therapeutic dinucleotide and derivatives |
Nov. 27, 2001 |
| 6277830 |
5'-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon |
Aug. 21, 2001 |
| 6277831 |
1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use |
Aug. 21, 2001 |
| 6258794 |
Treatment of mental conditions including depression |
Jul. 10, 2001 |
| 6255290 |
Antimutagenic compositions for treatment and prevention of photodamage to skin |
Jul. 3, 2001 |
| 6251870 |
Pharmaceutical composition for inhibiting growth of cancers |
Jun. 26, 2001 |
| 6239115 |
Dry flowable polyoxin compositions |
May. 29, 2001 |
| 6214801 |
Imidazo[1,2-a]pyridine C-nucleosides as antiviral agents |
Apr. 10, 2001 |
| 6204249 |
L-benzimidazole nucleosides |
Mar. 20, 2001 |
| 6180639 |
1,3-oxathiolane nucleoside analogues |
Jan. 30, 2001 |
| 6177409 |
Method for the site specific synthesis of novel 3-hydroxypyridin-4(1H)ons derivatives from aminomonosaccharides or aminoitols, products obtained by this method and their applications |
Jan. 23, 2001 |
| 6172046 |
Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection |
Jan. 9, 2001 |
| 6153594 |
5'-O-acylated antiviral nucleosides |
Nov. 28, 2000 |
| 6150337 |
Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes |
Nov. 21, 2000 |
| 6147056 |
Use of locally applied DNA fragments |
Nov. 14, 2000 |
| 6140309 |
Vasoactive effects and free radical generation by .beta.-amyloid peptides |
Oct. 31, 2000 |
| 6139838 |
Tissue plasminogen activator medicinal composition |
Oct. 31, 2000 |
| 6136791 |
Agent and method for treating disorders associated with cytidine deaminase or deoxycytidine deaminase overexpression |
Oct. 24, 2000 |
| 6132776 |
Methods of screening for nucleoside analogs that are incorporated by HIV reverse transcriptase and cause incorrect base pairing |
Oct. 17, 2000 |
| 6117849 |
S-(+)-adenosylmethionine and 3'-azido-2', 3'-dideoxy-nucleoside complexes as potent inhibitors of HIV-replication |
Sep. 12, 2000 |
| 6093698 |
Polysubstituted benzimidazoles as antiviral agents |
Jul. 25, 2000 |
| 6087342 |
Substrates having bound polysaccharides and bacterial nucleic acids |
Jul. 11, 2000 |
| 6077832 |
Antiviral benzimidazole nucleoside analogues and a method for their preparation |
Jun. 20, 2000 |
| 6071888 |
Composition for treating cancer |
Jun. 6, 2000 |
| 6069132 |
Phosphazole compounds |
May. 30, 2000 |
| 6063772 |
Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes |
May. 16, 2000 |
| 6046214 |
Heterocyclic compounds |
Apr. 4, 2000 |
| 6030960 |
Method of treating hepatitis virus infections |
Feb. 29, 2000 |
| 6030955 |
Methods of affecting intracellular phosphorylation of tyrosine using phosphorothioate oligonucleotides, and antiangiogenic and antiproliferative uses thereof |
Feb. 29, 2000 |
| 6020330 |
Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
Feb. 1, 2000 |
| 6013637 |
Anti-acne method and composition |
Jan. 11, 2000 |
| 6011019 |
Vasoactive effects and free radical generation by .beta.-amyloid peptides |
Jan. 4, 2000 |
| 6004939 |
Methods for modulation and inhibition of telomerase |
Dec. 21, 1999 |
| 5985879 |
Compounds useful for inhibition of farnesyl protein transferase |
Nov. 16, 1999 |
| 5977077 |
Xanthone analogs for the treatment of infectious diseases |
Nov. 2, 1999 |
| 5958890 |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
Sep. 28, 1999 |
| 5952310 |
Glycopeptide hexapeptides |
Sep. 14, 1999 |
| 5945407 |
Methods and compositions using butyrate esters of threitol |
Aug. 31, 1999 |
| 5942497 |
Purine compound and catecholamine compound containing compositions and methods for administration |
Aug. 24, 1999 |
| 5919771 |
Urea and thiourea derivatives of glycopeptides |
Jul. 6, 1999 |
| 5905071 |
Glycosylamides of 2-aminoacylamino-2-deoxy sugars |
May. 18, 1999 |
| 5891856 |
Method for protection against genotoxic mutagenesis |
Apr. 6, 1999 |
| 5885972 |
L-pyranosyl nucleosides |
Mar. 23, 1999 |
| 5874413 |
5'-substituted-ribofuranosyl benzimidazoles as antiviral agents |
Feb. 23, 1999 |
| 5869338 |
Method for protection against genotoxic mutagenesis |
Feb. 9, 1999 |
|
|
|
